Cardiff Lexington Corporation Stock

Equities

CDIX

US14146R6018

Healthcare Facilities & Services

Market Closed - OTC Markets 12:12:16 2024-04-26 pm EDT 5-day change 1st Jan Change
7.5 USD +130.77% Intraday chart for Cardiff Lexington Corporation +15.38% -50.13%
Sales 2022 12M Sales 2023 11.85M Capitalization 361K
Net income 2022 -5M Net income 2023 3M EV / Sales 2022 0.34 x
Net Debt 2022 3.83M Net Debt 2023 5.62M EV / Sales 2023 0.5 x
P/E ratio 2022 *
-
P/E ratio 2023
0.1 x
Employees 13
Yield 2022 *
-
Yield 2023
-
Free-Float 81.65%
More Fundamentals * Assessed data
Dynamic Chart
Earnings Flash (CDIX) CARDIFF LEXINGTON CORPORATION Posts Q4 Revenue $2.4M MT
Cardiff Lexington Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Cardiff Lexington Appoints Kevin Fitzgerald as Managing Director of Nova Ortho and Spine CI
Cardiff Lexington Corporation Appoints Zia Choe as Chief Accounting Officer CI
Cardiff Lexington Corporation Appoints Matthew Shafer as Chief Financial Officer CI
Earnings Flash (CDIX) CARDIFF LEXINGTON CORPORATION Reports Q3 Revenue $3.4M MT
Cardiff Lexington Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Earnings Flash (CDIX) CARDIFF LEXINGTON CORPORATION Reports Q2 Revenue $3.5M MT
Cardiff Lexington Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Cardiff Lexington Corporation has filed an IPO in the amount of $6 million. CI
Cardiff Lexington Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Cardiff Lexington Corporation Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Cardiff Lexington Corporation Auditor Raises 'Going Concern' Doubt CI
Cardiff Lexington Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Cardiff Lexington Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
More news
1 day+130.77%
1 week+50.00%
Current month+15.38%
1 month+50.00%
3 months+150.00%
6 months-75.06%
Current year-50.13%
More quotes
1 week
3.04
Extreme 3.04
7.50
1 month
3.04
Extreme 3.04
7.50
Current year
1.50
Extreme 1.5
22.56
1 year
1.50
Extreme 1.5
105.26
3 years
1.50
Extreme 1.5
1 804.51
5 years
1.50
Extreme 1.5
1 000 000.00
10 years
1.50
Extreme 1.5
1 000 000.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 66 15-05-31
Director of Finance/CFO 53 Jan. 01
Chairman 73 02-05-31
Members of the board TitleAgeSince
Chairman 73 02-05-31
Chief Executive Officer 66 15-05-31
Director/Board Member - -
More insiders
Date Price Change Volume
24-04-26 7.5 +130.77% 815
24-04-25 3.25 -35.00% 2,466

Delayed Quote OTC Markets, April 26, 2024 at 12:12 pm EDT

More quotes
Cardiff Lexington Corporation provides healthcare and financial services in the United States. The Company provides a full range of diagnostic and surgical services for injuries and disorders throughout the State of Florida with nine locations. The Company provides national tax resolution bookkeeping, and tax preparation services to individuals and companies that have federal and state tax liabilities. It also engages in real estate, developing 27 medium and high-density acres of dedicated riverfront property on the Salmon River, in Salmon, Idaho, adjacent to the Frank Church Wilderness Park, a wilderness park in the lower 48 states. Its portfolio of subsidiaries includes Nova Ortho & Spine, LLC, Platinum Tax Defenders, and Edge View Properties, Inc. Nova Ortho & Spine, LLC operates regional primary specialty and ancillary care facilities throughout Florida that provide traumatic injury victims with primary care evaluations, interventional pain management, and specialty consultation.
More about the company